Drug
depemokimab
Marketed as EXDENSUR.
Generic name
depemokimab
Brand names
EXDENSUR
First FDA approval
2025-12-16
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761458 | EXDENSUR | 2025-12-16 | GLAXOSMITHKLINE LLC |
Manufacturers
GLAXOSMITHKLINE LLC
Frequently asked questions
When was depemokimab FDA approved?
Earliest FDA approval on record: 2025-12-16.
What brand names are sold as depemokimab?
EXDENSUR.
Sources
Appeal a depemokimab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com